A Maryland based biotechnology company announced the coronavirus vaccine it developed is moving into an efficacy trial phase.
Katie Johnston reports.
Novavax Initiates COVID-19 Vaccine Trial In South Africa
Credit: WJZ Baltimore
Duration: 00:32s
0 shares
1 views